BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2329505)

  • 1. Activation of protein kinase C inhibits internalization and downregulation of muscarinic receptors in 1321N1 human astrocytoma cells.
    Hoover RK; Toews ML
    J Pharmacol Exp Ther; 1990 Apr; 253(1):185-91. PubMed ID: 2329505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of homologous desensitization and internalization of muscarinic receptors in primary cultures of neonatal corticostriatal neurons.
    Eva C; Gamalero SR; Genazzani E; Costa E
    J Pharmacol Exp Ther; 1990 Apr; 253(1):257-65. PubMed ID: 2158546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells.
    Gucker S; Bidlack JM
    Mol Pharmacol; 1992 Oct; 42(4):656-65. PubMed ID: 1331757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
    Meeker RB; Harden TK
    Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an agonist-induced, ATP-dependent change in muscarinic receptors of intact 1321N1 cells.
    Hoover RK; Toews ML
    J Pharmacol Exp Ther; 1989 Oct; 251(1):63-70. PubMed ID: 2795471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH; Fleming IN; Downes CP
    Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C.
    Rousell J; Haddad EB; Mak JC; Webb BL; Giembycz MA; Barnes PJ
    Mol Pharmacol; 1996 Apr; 49(4):629-35. PubMed ID: 8609890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells.
    Kurita M; Nishino S; Ohtomo K; Rai M; Shirakawa H; Mashiko H; Niwa S; Nakahata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):600-4. PubMed ID: 17258372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation.
    Nieto M; Kennedy E; Goldstein D; Brown JH
    Mol Pharmacol; 1994 Sep; 46(3):406-13. PubMed ID: 7935319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-induced alteration in the membrane form of muscarinic cholinergic receptors.
    Harden TK; Petch LA; Traynelis SF; Waldo GL
    J Biol Chem; 1985 Oct; 260(24):13060-6. PubMed ID: 4055732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-induced desensitization of cholinergically stimulated phosphoinositide breakdown is independent of endogenously activated protein kinase C in HT-29 human colon carcinoma cells.
    Kopp R; Mayer P; Pfeiffer A
    Biochem J; 1990 Jul; 269(1):73-8. PubMed ID: 2165399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of muscarinic M1 receptors of murine neuroblastoma cells (clone N1E-115) without receptor down-regulation and protein kinase C activity.
    Kanba S; Kanba KS; McKinney M; Pfenning M; Abraham R; Nomura S; Enloes L; Mackey S; Richelson E
    Biochem Pharmacol; 1990 Sep; 40(5):1005-14. PubMed ID: 2167677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium chloride at a therapeutic concentration reduces Ca2+ response in protein kinase C down-regulated human astrocytoma cells.
    Kurita M; Mashiko H; Rai M; Kumasaka T; Kouno Si; Niwa Si; Nakahata N
    Eur J Pharmacol; 2002 May; 442(1-2):17-22. PubMed ID: 12020677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for alpha 1-adrenergic receptor internalization in DDT1 MF-2 cells following exposure to agonists plus protein kinase C activators.
    Cowlen MS; Toews ML
    Mol Pharmacol; 1988 Sep; 34(3):340-6. PubMed ID: 2901664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of protein kinase C induces rapid internalization and subsequent degradation of muscarinic acetylcholine receptors in neuroblastoma cells.
    Liles WC; Hunter DD; Meier KE; Nathanson NM
    J Biol Chem; 1986 Apr; 261(12):5307-13. PubMed ID: 3082882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of protein kinase C alpha and epsilon isozymes in DNA synthesis induced by muscarinic receptors in a glial cell line.
    Guizzetti M; Wei M; Costa LG
    Eur J Pharmacol; 1998 Oct; 359(2-3):223-33. PubMed ID: 9832394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
    Fisher SK
    Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor reserve in the calcium-dependent cyclic AMP response of astrocytoma cells to muscarinic receptor stimulation: demonstration by agonist-induced desensitization, receptor inactivation, and phorbol ester treatment.
    Harden TK; Heng MM; Brown JH
    Mol Pharmacol; 1986 Sep; 30(3):200-6. PubMed ID: 3018476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
    Mei L; Lai J; Roeske WR; Fraser CM; Venter JC; Yamamura HI
    J Pharmacol Exp Ther; 1989 Feb; 248(2):661-70. PubMed ID: 2537406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.